Search results for " Type 1"

showing 10 items of 430 documents

The relevant role of family history in predicting type 2 diabetes occurrence.

2019

On June 6, 2019, the Polish Archives of Internal Medicine published an interesting article by Szczerbiński et al,1 entitled “Efficacy of family history, genetic risk score, and physical activity in assessing the prevalence of type 2 diabetes.” This editorial is a commentary on this paper, intending to highlight, one more time, the importance of a positive family history (FH+) of type 2 diabetes (T2D) for estimating diabetes occurrence in the adult population as well as the importance of physical activity (PA) for maintaining optimal body composition and a low incidence rate of chronic disease.2 Since 2011, my research group has provided periodical pieces of evidence (2011, 2013, and 2014) a…

Gerontologybusiness.industryPhysical activityMEDLINEType 2 diabetesmedicine.diseaseFamily History T2DM Exercise Physiology Physical Activity Health PromotionHealth promotionDiabetes Mellitus Type 1Diabetes Mellitus Type 2Risk FactorsDiabetes mellitusInternal MedicinePrevalenceMedicineHumansExercise physiologyFamily historybusinessExercisePolish archives of internal medicine
researchProduct

The diabetic cataract: an unusual presentation in a young subject: case report.

1997

This case report concerns a 14-year-old female patient, whose insulin-dependent diabetes mellitus was displayed by one infrequent complication, the cataract. This is an unusual manifestation in a 14-year-old patient; indeed, there are many findings in experimental animals demonstrating the development of this complication by maintaining blood glucose levels above 12 mM. After surgical therapy, complete vision was recovered, but we think that an earlier diagnosis and therapy of metabolic derangement of diabetes may have avoided this complication.

GlycosuriaBlood Glucosemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismEye diseaseHypercholesterolemiaCataract ExtractionKetone BodiesCataractEndocrinologyGlycosuriaDiabetes mellitusFemale patientInternal MedicinemedicineHumansHypertriglyceridemiaMetabolic derangementbusiness.industrymedicine.diseaseDiabetic cataractSurgeryDiabetes Mellitus Type 1FemalePresentation (obstetrics)medicine.symptomComplicationbusinessJournal of diabetes and its complications
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adul…

2010

Mesenchymal stem cells (MSC) are uniquely capable of crossing germinative layers borders (i.e. are able to differentiate towards ectoderm-, mesoderm- and endoderm-derived cytotypes) and are viewed as promising cells for regenerative medicine approaches in several diseases. Type I diabetes therapy should potentially benefit from such differentiated cells: the search for alternatives to organ/islet transplantation strategies via stem cells differentiation is an ongoing task, significant goals having been achieved in most experimental settings (e.g. insulin production and euglycaemia restoration), though caution is still needed to ensure safe and durable effects in vivo. MSC are obtainable in …

Graft RejectionCancer ResearchCellular differentiationCell Culture TechniquesClinical uses of mesenchymal stem cellsBiologyMesenchymal Stem Cell TransplantationRegenerative medicineUmbilical CordImmunomodulationMesenchymal stem cells Umbilical cord Wharton’s jelly Type 1 diabetes Beta cells Differentiation markers Pancreas development Inflammation Immune modulation HypoimmunogenicityInsulin-Secreting CellsWharton's jellyAnimalsHumansRegenerationEmbryonic Stem CellsSettore BIO/16 - Anatomia UmanaRegeneration (biology)Mesenchymal stem cellCell DifferentiationMesenchymal Stem CellsCell BiologyAntigens DifferentiationTransplantationAdult Stem CellsDiabetes Mellitus Type 1Adipose TissueImmunologyCancer researchCord Blood Stem Cell TransplantationStem cellStem Cell Reviews and Reports
researchProduct

Cellular and tissue expression of DAPIT, a phylogenetically conserved peptide

2011

DAPIT (Diabetes Associated Protein in Insulin-sensitive Tissues) is a small, phylogenetically conserved, 58 amino acid peptide that was previously shown to be down-regulated at mRNA level in insulin-sensitive tissues of type 1 diabetes rats. In this study we characterize a custom made antibody against DAPIT and confirm the mitochondrial presence of DAPIT on cellular level. We also show that DAPIT is localized in lysosomes of HUVEC and HEK 293T cells. In addition, we describe the histological expression of DAPIT in several tissues of rat and man and show that it is highly expressed especially in cells with high aerobic metabolism and epithelial cells related to active transport of nutrients …

HistologyCellular respirationProtein subunitBiophysicsPeptideV-ATPaseBiologyMitochondrionAntibodiesMitochondrial ProteinsHuman Umbilical Vein Endothelial CellsV-ATPaseAnimalsHumansmitochondrionta315lcsh:QH301-705.5PhylogenyDAPIT mitochondrion V-ATPase type 1 diabeteschemistry.chemical_classificationRegulation of gene expressionOriginal Papertype 1 diabetes.HEK 293 cellsMembrane ProteinsCell BiologyProton PumpsCell biologyMitochondriaRatsHEK293 CellsMembrane proteinchemistryBiochemistryGene Expression Regulationlcsh:Biology (General)Organ SpecificityLysosomesDAPITEuropean Journal of Histochemistry
researchProduct

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

2018

[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid glucose gradient. The aim of the present study was to assess the role of plasma insulin (PI) and hypoglycemia itself in the plasma and interstitial SC fluid glucose concentration in patients with type 1 diabetes mellitus. Methods: Eleven subjects with type 1 diabetes (age 36.59.1 years, HbA(1c) 7.90.4% [62.8 +/- 2.02mmol/mol]; mean +/- standard deviation) were evaluated under hyperinsulinemic euglycemia and hypoglycemia. Each subject underwent two randomized crossover clam…

Hypoglycemia; Interstitial glucose; Subcutaneous glucose sensing; Endocrinology Diabetes and Metabolism; Endocrinology; Medical Laboratory TechnologyAdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismHypoglycemiaAffect (psychology)03 medical and health sciences0302 clinical medicineEndocrinologySubcutaneous glucose sensingInternal medicineDiabetes mellitusMedicineHumansInsulinskin and connective tissue diseases030304 developmental biology0303 health sciencesbusiness.industryContinuous glucose monitoringInsulinnutritional and metabolic diseasesInterstitial glucoseExtracellular FluidMiddle Agedmedicine.diseaseHypoglycemiaINGENIERIA DE SISTEMAS Y AUTOMATICA3. Good healthDiabetes and MetabolismMedical Laboratory TechnologyEndocrinologyDiabetes Mellitus Type 1GlucoseInterstitial glucoseFemalesense organsPlasma insulinbusiness
researchProduct

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabe…

2019

The aim of the study was to assess the amount of orally administered carbohydrates needed to maintain euglycemia during moderate-intensity exercise in individuals with type 1 diabetes. Nine participants with type 1 diabetes (four women, age 32.1 &plusmn

Insulin degludecAdultBlood GlucoseMalemedicine.medical_specialtyinsulintype 1 diabetesmedicine.medical_treatmentcarbohydratesBlood sugar030209 endocrinology & metabolismPhysical exerciselcsh:TX341-641Article03 medical and health sciencesYoung Adult0302 clinical medicineOxygen ConsumptionInternal medicineDiabetes mellitusmedicineDietary CarbohydratesHumansType 1 diabetesNutrition and DieteticsCross-Over Studiesexercisebusiness.industryInsulin030229 sport sciencesmedicine.diseaseCrossover studyHypoglycemiaBicyclingEndocrinologyDiabetes Mellitus Type 1Blood chemistryFemaleeuglycemiabusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Rapid-Acting Insulin Analogues in Basal-Bolus Regimens in Type 1 Diabetes Mellitus

2010

ABSTRACT Objective To compare rapid-acting insulin analogues with regular human insulin in terms of hemoglobin A1c, hypoglycemia, and insulin dose when used in a basal-bolus regimen in patients with type 1 diabetes mellitus. Methods MEDLINE and congress proceedings were searched for randomized controlled trials comparing pran- dial insulins in a basal-bolus regimen in adults or children/ adolescents with type 1 diabetes. Studies in pregnancy, ob- servational studies, studies that compared premixed insulin or continuous subcutaneous insulin infusion/insulin pumps, and studies where the basal insulin was also changed were excluded. Only studies reporting baseline-endpoint change in insulin do…

Insulin glulisinemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHypoglycemiaInsulin aspartEndocrinologyPregnancyDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsInsulinInsulin lisproGlycemicType 1 diabetesInsulin Lisprobusiness.industryInsulinGeneral Medicinemedicine.diseaseInsulin Long-ActingDiabetes Mellitus Type 1EndocrinologyFemalebusinessmedicine.drugEndocrine Practice
researchProduct

Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observat…

2021

While data on the efficacy and safety of continuous glucose monitoring (CGM) exist across a broad age spectrum, it is limited in very young children with type 1 diabetes (T1D). We aimed to assess real-world data in this high-risk population, focusing on glycemic variability and metrics beyond HbA1c. A 12-month multi-national, prospective, observational, registry-based cohort study in children with T1D aged 1-7 years compared glucose control using real-time CGM and using fingerstick blood glucose monitoring (BGM) alone. The prespecified primary endpoint was a difference in coefficient of variation (CV) between the CGM users and BGM-only cohort. Among 227 individuals using insulin pumps (42% …

Insulin pumpBlood GlucosePediatricsmedicine.medical_specialtyendocrine system diseasesFingerstickEndocrinology Diabetes and MetabolismPopulationChildren; Continuous glucose monitoring; Insulin pump; Toddlers; Type 1 diabetesCohort StudiesHDE END PEDEndocrinologyInsulin Infusion SystemsInternal MedicinemedicineHumansHypoglycemic AgentsInsulinInsulin pumpeducationChildChildrenContinuous glucose monitoringchildren; continuous glucose monitoring; insulin pump; toddlers; type 1 diabetesGlycemicBlood glucose monitoringGlycated HemoglobinToddlerseducation.field_of_studyType 1 diabetesmedicine.diagnostic_testEndocrinology; Metabolismbusiness.industryBlood Glucose Self-Monitoringnutritional and metabolic diseasesDiabetes type 1medicine.diseaseType 1 diabetesDiabetes Mellitus Type 1GlucoseChild PreschoolCohortbusinessCohort studyDiabetes Obesity & Metabolism
researchProduct

Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pe…

2021

OBJECTIVE Insulin delivery methods, glucose-monitoring modalities, and related outcomes were examined in a large, international, diverse cohort of children and adolescents with type 1 diabetes from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) -Registry. RESEARCH DESIGN AND METHODS Participants with type 1 diabetes of >= 1 year, aged <= 18 years, and who had documented pump or sensor usage during the period August 2017-July 2019 were stratified into four categories: injections-no sensor (referent); injections + sensor; pump-no sensor; and pump + sensor. HbA(1c) and proportion of patients with diabetic ketoacidosis (DKA) or severe hyp…

Insulin pumpKetoacidosisBlood Glucosemedicine.medical_specialtyDiabetic ketoacidosisAdolescentEndocrinology Diabetes and MetabolismDpv030209 endocrinology & metabolismHypoglycemia03 medical and health sciences0302 clinical medicineInsulin Infusion SystemsDiabetes mellitusInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsInsulin030212 general & internal medicineRegistriesChildGlycemicAdvanced and Specialized NursingGlycated HemoglobinType 1 diabetesbusiness.industryBlood Glucose Self-Monitoringmedicine.diseaseQualityHypoglycemiaKetoacidosisDiabetes Mellitus Type 1CohortTherapybusinessDiabetes Care
researchProduct

A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk

2010

Combined analyses of gene networks and DNA sequence variation can provide new insights into the aetiology of common diseases that may not be apparent from genome-wide association studies alone. Recent advances in rat genomics are facilitating systems-genetics approaches. Here we report the use of integrated genome-wide approaches across seven rat tissues to identify gene networks and the loci underlying their regulation. We defined an interferon regulatory factor 7 (IRF7)-driven inflammatory network (IDIN) enriched for viral response genes, which represents a molecular biomarker for macrophages and which was regulated in multiple tissues by a locus on rat chromosome 15q25. We show that Epst…

Interferon Regulatory Factor-7Quantitative Trait LociGenome-wide association studyLocus (genetics)Single-nucleotide polymorphismBiologyQuantitative trait locusPolymorphism Single NucleotideArticleReceptors G-Protein-Coupled03 medical and health sciences0302 clinical medicineAnimalsHumansGene Regulatory NetworksGenetic Predisposition to DiseaseGene030304 developmental biologyGeneticsInflammation0303 health sciencesMultidisciplinaryBase SequenceChromosomes Human Pair 13MacrophagesChromosomes MammalianImmunity Innate3. Good healthRatsDiabetes Mellitus Type 1Genetic LociOrgan SpecificityVirusesIRF7Trans-acting030217 neurology & neurosurgeryInterferon regulatory factorsGenome-Wide Association Study
researchProduct